To date, TET2 promoter hypermethylation had been observed for low-grade diffuse gliomas, a subset of Ph-negative MPN and pediatric acute lymphoblastic leukemia (ALL) (Chim et al. 2010; Musialik et al. 2014). This evidence concerns the gene TET2 and acute lymphoblastic leukemia.